The London-listed firm had to pause global trials of its potential vaccine for COVID-19 after an unexplained illness in a participant, which sent its shares lower as the move was seen as dimming prospects for an early rollout.AstraZeneca did not immediately respond to a Reuters request for comment.
AstraZeneca coronavirus vaccine trials could resume next week – report
By REUTERS
11/05/2024 01:17 AM
By REUTERS
11/05/2024 01:02 AM
By REUTERS
11/04/2024 10:04 PM
By REUTERS
11/04/2024 10:01 PM
By REUTERS
11/04/2024 09:51 PM
By REUTERS
11/04/2024 08:38 PM
By REUTERS
11/04/2024 07:15 PM